We discuss the seven ways pharmacy investigations can begin:
1. Data Analysis: Agencies like the DEA and DOJ monitor prescription data for unusual pa
As Featured In
New Episodes
#pharma #pharmaceuticals
Website: http://www.darshantalks.com
Law Firm: http://www.kulkarnilawfirm.com
Twitter: https://twitter.com/darshantalks
Link
#pharma #pharmaceuticals
Website: http://www.darshantalks.com
Law Firm: http://www.kulkarnilawfirm.com
Twitter: https://twitter.com/darshantalks
Link
Clinical Trials
#pharma #pharmaceuticals
Website: http://www.darshantalks.com
Law Firm: http://www.kulkarnilawfirm.com
Twitter: https://twitter.com/darshantalks
Link
We discuss six critical errors in the informed consent process:
1. Exclusion of Principal Investigator: PI was not allowed to engage in the informed
Informed consent is a crucial aspect of clinical trials, ensuring that prospective subjects understand the benefits, risks, and potential harms of par
Medical Affairs
McKinsey’s vision for Medical Affairs in 2030 envisions profound integration of digital tools, analytical innovation, evidence generation, and leade
In this episode of the DarshanTalks Podcast, host Darshan Kulkarni Pharm.D, MS, Esq. welcomes Biopharma Medical Affairs expert, Irene von Hennigs, Pha
In today’s episode of DarshanTalks Podcast, host Darshan Kulkarni welcomes guest Patti Zettler to talk about the non-therapeutic uses of drugs and d